US2021244621A1PendingUtilityA1

Systems and methods for promoting medication adherence

Assignee: AGAPE ASSETS LLCPriority: Nov 9, 2016Filed: Apr 1, 2021Published: Aug 12, 2021
Est. expiryNov 9, 2036(~10.3 yrs left)· nominal 20-yr term from priority
G16H 20/13A61F 9/0008A61J 7/0436A61F 2250/0002A61J 7/0418A61J 7/0481A61J 7/0427A61J 2200/30A61F 2250/0085A61F 2250/0001
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A medication adherence device may include a unibody and a station. The unibody may include: a unibody housing configured to be removably coupled to a medicine container; an inertial measurement unit configured to record motion data describing the movement of the unibody, and therefore describing the movement of a medicine container that the unibody is coupled to; and a unibody data interface in communication with the inertial measurement unit. The station may include: a station data interface configured to receive motion data from the unibody data interface; and a station processing unit in communication with the station data interface, the station processing unit configured to generate medication access information using the motion data. Preferably, data and power may be communicated between the unibody and station when the unibody is positioned proximate to the station, such as by being positioned in a station cavity.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A medication adherence device, the device comprising:
 a unibody, the unibody having:
 i. a unibody housing configured to be removably coupled to a medicine container; 
 ii. an inertial measurement unit, the inertial measurement unit configured to record motion data describing movement of the unibody; and 
 iii. a unibody data interface in communication with the inertial measurement unit; and 
   a station, the station having:
 i. a station data interface, the station data interface configured to receive motion data from the unibody data interface; and 
 ii. a station processing unit in communication with the station data interface, the station processing unit configured to generate medication access information using the motion data. 
   
     
     
         2 . The device of  claim 1 , wherein the station further comprises a display configured to visually display the medication access information. 
     
     
         3 . The device of  claim 1 , further comprising a network interface, the network interface configured to communicate the medication access information to a network. 
     
     
         4 . The device of  claim 3 , wherein the network interface is a wireless network interface. 
     
     
         5 . The device of  claim 1 , wherein the station further comprises a station cavity configured to receive a portion of the unibody. 
     
     
         6 . The device of  claim 1 , wherein the unibody data interface comprises a Radio Frequency Identification (RFID) Tag and the station data interface comprises a Radio Frequency Identification (RFID) Reader. 
     
     
         7 . The device of  claim 1 , wherein the unibody comprises a unibody charging element, and wherein the station comprises a station charging element configured to communicate power to the unibody charging element. 
     
     
         8 . The device of  claim 7 , wherein the station charging element communicates power to the unibody charging element via inductive charging. 
     
     
         9 . The device of  claim 1 , wherein the unibody comprises a unibody processing unit. 
     
     
         10 . The device of  claim 9 , wherein the unibody processing unit is configured to communicate motion data from the inertial measurement unit to the unibody data interface.

Join the waitlist — get patent alerts

Track US2021244621A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.